PYC (PYC) News
Follow PYC (PYC) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 5 public stories across 4 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
PYC Therapeutics Target Price Raised 30% to A$3.00/Share by Bell Potter>PYC.AU
PYC Therapeutics Target Price Raised 30% to A$3.00/Share by Bell Potter>PYC.AU
NEWS | Sep 15, 2026, 01:21 AM UTC
L
PYC flags multiple clinical readouts and clean safety data ahead
PYC says the next 18 months will bring multiple human safety and efficacy readouts across four clinical programs, with its PKD program nearing a transition to registrational studies. It cites clean safety data and a stro
EQUITY | Sep 04, 2026, 03:08 AM UTC
L
PYC: Multiple clinical readouts and a strong safety profile drive momentum toward late-stage trials
Upcoming 18 months will see multiple human safety and efficacy readouts across four clinical programs, with the PKD program advancing toward registrational studies and showing a clean safety profile so far. Organizationa
EQUITY | Sep 04, 2026, 01:42 AM UTC
L
PYC Therapeutics eyes key RNA therapy clinical milestones by 2028
PYC Therapeutics is advancing RNA therapies for rare diseases, progressing multiple clinical programs. Efficacy data is expected in the next 18 months, with registrational studies targeted for 2028.
EQUITY | Sep 03, 2026, 11:29 PM UTC
L
Physiomics PLC REG filing on shareholdings
TradingView News reports a REG filing by Physiomics PLC regarding holdings in the company.
EQUITY | Aug 26, 2026, 09:00 AM UTC